Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase kinase kinase 8 |
---|
Ligand | BDBM50317233 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_631522 (CHEMBL1117425) |
---|
IC50 | >10000±n/a nM |
---|
Citation | Boschelli, DH; Wang, D; Wang, Y; Wu, B; Honores, EE; Barrios Sosa, AC; Chaudhary, I; Golas, J; Lucas, J; Boschelli, F Optimization of 7-alkene-3-quinolinecarbonitriles as Src kinase inhibitors. Bioorg Med Chem Lett20:2924-7 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase kinase kinase 8 |
---|
Name: | Mitogen-activated protein kinase kinase kinase 8 |
Synonyms: | C-COT | COT | COT proto-oncogene serine/threonine-protein kinase | Cancer Osaka thyroid oncogene | ESTF | M3K8_HUMAN | MAP3K8 | Tpl-2 | Tumor Progression Loci-2 Kinase (COT) | Tumor progression locus 2 |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 52916.89 |
Organism: | Homo sapiens (Human) |
Description: | P41279 |
Residue: | 467 |
Sequence: | MEYMSTGSDNKEEIDLLIKHLNVSDVIDIMENLYASEEPAVYEPSLMTMCQDSNQNDERS
KSLLLSGQEVPWLSSVRYGTVEDLLAFANHISNTAKHFYGQRPQESGILLNMVITPQNGR
YQIDSDVLLIPWKLTYRNIGSDFIPRGAFGKVYLAQDIKTKKRMACKLIPVDQFKPSDVE
IQACFRHENIAELYGAVLWGETVHLFMEAGEGGSVLEKLESCGPMREFEIIWVTKHVLKG
LDFLHSKKVIHHDIKPSNIVFMSTKAVLVDFGLSVQMTEDVYFPKDLRGTEIYMSPEVIL
CRGHSTKADIYSLGATLIHMQTGTPPWVKRYPRSAYPSYLYIIHKQAPPLEDIADDCSPG
MRELIEASLERNPNHRPRAADLLKHEALNPPREDQPRCQSLDSALLERKRLLSRKELELP
ENIADSSCTGSTEESEMLKRQRSLYIDLGALAGYFNLVRGPPTLEYG
|
|
|
BDBM50317233 |
---|
n/a |
---|
Name | BDBM50317233 |
Synonyms: | (E)-4-(2,4-dichloro-5-methoxyphenylamino)-6-methoxy-7-(4-(4-methylpiperazin-1-yl)but-1-enyl)quinoline-3-carbonitrile | CHEMBL1088240 |
Type | Small organic molecule |
Emp. Form. | C27H29Cl2N5O2 |
Mol. Mass. | 526.457 |
SMILES | COc1cc(Nc2c(cnc3cc(\C=C\CCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl |
Structure |
|